Outcome: sleep onset latency (SOL) |
Benzodiazepines vs inactive controls | 54 | SR + MA | | + 1 | + 1 | + 1 |
Non-benzodiazepines vs inactive controls | 59 | SR + MA | | + 2 | + 2 | |
SR | | | + 2 | − 1 |
Non-benzodiazepines vs active controls | 1 | SR | | | | − 1 |
Suvorexant vs inactive controls | 3 | SR + MA | | + 3 | | |
SR | | | + 1 | |
Antidepressants vs inactive controls | 21 | SR + MA | | +/− 2 | + 1 | |
SR | | +/− 1 | +/− 2 | +/− 1 |
Antidepressants vs active controls | 1 | SR | | | + 3 | |
Antipsychotics vs inactive controls | 5 | SR + MA | | | | |
SR | | | + 1 | + 2 |
Melatonin vs inactive controls | 24 | SR + MA | | + 3 | | + 1 |
SR | | | + 1/− 1 | +/− 1 |
Diphenhydramine vs inactive controls | 5 | SR + MA | | | +/− 1 | |
SR | | | +/− 2 | |
Cognitive behavioral therapy vs inactive controls | 89 | SR + MA | + 3 | + 6 | + 6 | − 2 |
SR | | + 5 | + 2 | + 1 |
Cognitive behavioral therapy vs active controls | 7 | SR + MA | | | + 1/− 1 | |
SR | | | | |
Behavioral Interventions vs inactive controls | 22 | SR + MA | | | − 2 | |
SR | | + 1 | + 1 | |
Mindfulness-based Interventions vs inactive controls | 2 | SR + MA | | + 1 | | |
Combination Therapies vs inactive controls | 1 | SR | | | + 1 | |
Outcome: total sleep time (TST) |
Benzodiazepines vs inactive controls | 33 | SR + MA | | | + 1 | + 1 |
SR | | | | + 1 |
Non-benzodiazepines vs inactive controls | 41 | SR + MA | | + 2 | + 1 | |
SR | | | + 1 | + 1 |
Non-benzodiazepines vs active controls | 1 | SR | | | | + 1 |
Suvorexant vs inactive controls | 3 | SR + MA | | + 2 | + 1 | |
SR | | | + 1 | |
Antidepressants vs inactive controls | 24 | SR + MA | | + 4 | | |
SR | | +/− 1 | +/− 2 | +/− 1 |
Antidepressants vs active controls | 1 | SR | | | − 2 | |
Antipsychotics vs inactive controls | 4 | SR | | | | +/− 3 |
Melatonin vs inactive controls | 30 | SR + MA | − 1 | + 2/− 1 | − 1 | − 1 |
SR | | + 1 | +/− 1 | +/− 2 |
Diphenhydramine vs inactive controls | 4 | SR + MA | | | − 1 | |
SR | | | +/− 2 | |
Cognitive behavioral therapy vs inactive controls | 72 | SR + MA | + 1/− 1 | + 4/− 2 | + 1/− 4 | + 1/− 1 |
SR | | +/− 2 | +/− 1 | |
Cognitive behavioral therapy vs active controls | 2 | SR + MA | | | − 2 | |
SR | | − 1 | | |
Behavioral Interventions vs inactive controls | 7 | SR + MA | | | − 1 | |
SR | | | − 1 | − 1 |
Mindfulness-based Interventions vs inactive controls | 2 | SR + MA | | − 1 | | |
Combination therapies vs inactive controls | 4 | SR + MA | | | − 1 | |
SR | | | + 1 | |
Outcome: wake after sleep onset (WASO) |
Benzodiazepines vs inactive controls | 4 | SR + MA | | | + 1 | |
Non-benzodiazepines vs inactive controls | 16 | SR + MA | | − 1 | + 1 | |
SR | | | + 2 | + 1 |
Non-benzodiazepines vs active controls | 3 | SR + MA | | | | |
SR | | | + 1 | |
Suvorexant vs inactive controls | 3 | SR + MA | | + 1 | + 1 | |
SR | | | + 1 | |
Antidepressants vs inactive controls | 13 | SR + MA | | + 2 | | |
SR | | + 1 | + 2 | + 2 |
Antidepressants vs active controls | 1 | SR | | | + 2 | |
Melatonin vs inactive controls | 13 | SR + MA | | − 1 | − 2 | |
SR | | | | + 2 |
Diphenhydramine vs inactive controls | 1 | SR | | | | − 1 |
Cognitive behavioral therapy vs inactive controls | 70 | SR + MA | + 1/− 1 | + 5 | + 7/− 2 | + 1 |
SR | | + 3 | + 3 | |
Cognitive behavioral therapy vs active controls | 17 | SR + MA | | | − 2 | |
SR | | + 1 | | + 1 |
Behavioral Interventions vs inactive controls | 9 | SR + MA | | +/− 1 | +/− 1 | |
SR | | | + 1 | |
Outcome: sleep quality |
Benzodiazepines vs inactive controls | 2 | SR + MA | | | − 1 | |
Non-benzodiazepines vs inactive controls | 9 | SR + MA | | + 1 | + 1 | |
SR | | | + 2 | |
Suvorexant vs inactive controls | 3 | SR + MA | | + 1 | | |
Antidepressants vs inactive controls | 13 | SR + MA | | + 1 | | |
SR | | | + 3 | |
Antidepressants vs active controls | 1 | SR | | | − 1 | |
Antipsychotics vs inactive controls | 8 | SR | | | + 2 | + 2 |
Melatonin vs inactive controls | 23 | SR + MA | | − 3 | + 1/− 1 | |
SR | | | +/− 3 | + 2 |
Diphenhydramine vs inactive controls | 1 | SR | | | | − 1 |
Cognitive behavioral therapy vs inactive controls | 47 | SR + MA | | + 5/− 1 | + 5/− 2 | + 1 |
SR | | + 1 | + 2/− 1 | |
Cognitive behavioral therapy vs active controls | 4 | SR | | | − 2 | |
Behavioral Interventions vs inactive controls | 12 | SR + MA | | | + 1 | |
SR | | + 1/− 1 | + 3/− 1 | |
Behavioral Interventions vs active controls | 8 | SR + MA | | | + 1 | |
Mindfulness-based Interventions vs inactive controls | 4 | SR + MA | | + 1 | | |
SR | | | | + 1 |
Combination Therapies vs inactive controls | 1 | SR | | | + 1 | |
Outcome: sleep satisfaction |
Antipsychotics vs inactive controls | 1 | SR | | | | − 1 |
Melatonin vs inactive controls | 1 | SR | | | + 1 | |
Cognitive behavioral therapy vs inactive controls | 2 | SR | | + 1 | | |
Behavioral Interventions vs inactive controls | 1 | SR | | | + 1 | |
Outcome: sleep efficiency |
Non-benzodiazepines vs inactive controls | 4 | SR + MA | | + 1 | | |
SR | | | | +/− 1 |
Non-benzodiazepines vs active controls | 2 | SR | | | | +/− 1 |
Antidepressants vs inactive controls | 15 | SR + MA | | + 2 | | |
SR | | + 1 | + 1 | +/− 2 |
Antipsychotics vs inactive controls | 2 | SR | | | | + 3 |
Melatonin vs inactive controls | 19 | SR + MA | − 1 | + 1/− 2 | − 1 | |
SR | | | +/− 1 | + 1/− 1 |
Diphenhydramine vs inactive controls | 2 | SR | | | +/− 1 | |
Cognitive behavioral therapy vs inactive controls | 83 | SR + MA | + 1 | + 7/− 1 | + 5 | + 1 |
SR | | + 4 | + 5 | |
Cognitive behavioral therapy vs active controls | 4 | SR + MA | | | − 2 | |
SR | | + 1 | + 1 | |
Behavioral Interventions vs inactive controls | 4 | SR | | | + 2 | |
Mindfulness-based Interventions vs inactive controls | 5 | SR + MA | | − 1 | | |
SR | | | +/− 1 | |
Outcome: Insomnia Severity Index (ISI) |
Suvorexant vs inactive controls | 3 | SR + MA | | + 1 | + 1 | |
SR | | | + 1 | |
Antidepressants vs inactive controls | 2 | SR + MA | | + 1 | | |
Antipsychotics vs inactive controls | 1 | SR | | | | + 1 |
Diphenhydramine vs inactive controls | 1 | SR | | | + 1 | |
Cognitive behavioral therapy vs inactive controls | 46 | SR + MA | | + 4/− 1 | + 5 | |
SR | | + 3 | + 2 | |
Cognitive behavioral therapy vs active controls | 2 | SR + MA | | | − 1 | |
Outcome: fatigue severity |
Cognitive behavioral therapy vs inactive controls | 26 | SR + MA | +/− 1 | +/− 2 | | |
SR | | + 2 | | |
Behavioral Interventions vs inactive controls | 2 | SR | | | − 1 | |
Outcome: health-related quality of life |
Non-benzodiazepines vs inactive controls | 4 | SR | | +/− 1 | | |
Melatonin vs inactive controls | 1 | SR | | | | + 1 |
Cognitive behavioral therapy vs inactive controls | 7 | SR | | + 2 | + 2 | |
Cognitive behavioral therapy vs active controls | 1 | SR | | | + 1 | |
Outcome: hangover/morning sedation |
Non-benzodiazepines vs inactive controls | 1 | SR | | | | − 1 |
Non-benzodiazepines vs active controls | 1 | SR | | | | − 1 |
Suvorexant vs inactive controls | 3 | SR + MA | | + 2 | | |
Antipsychotics vs inactive controls | 2 | SR | | | | + 1 |
Outcome: accidental injury |
Suvorexant vs inactive controls | 3 | SR + MA | | + 2 | | |
Outcome: addiction, dependence, or diversion |
Non-benzodiazepines vs inactive controls | 3 | SR | | | +/− 1 | |
Non-benzodiazepines vs active controls | 3 | SR | | | +/− 1 | |
Suvorexant vs inactive controls | 3 | SR + MA | | + 2 | | |